Drugs / iAPA-DC/CTL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02529579 | Jun 2015 → Dec 2018 | pancreatic ductal adenocarcinoma | Changhai Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iAPA-DC/CTL | “iAPA-DC/CTL adoptive cellular immunotherapy” NCT02529579 ↗ |
| Modality | Cell therapy | “adoptive cellular immunotherapy” NCT02529579 ↗ |